Ftse Mib
34.186,18
0,07%
DAX
19.909,14
-0,25%
S&P 500
5.881,63
-0,43%
NASDAQ
19.310,79
-0,90%
Bitcoin
94.918,21
0,56%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ BioXcel Therapeutics Inc (BTAI) BioXcel Therapeutics Inc (BTAI) Notizie

BioXcel Therapeutics Inc

BTAI
0,3691
0,0022 (0,60%)
01 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/12/202422:15EDGAR2Form DEF 14A - Other definitive proxy statements
18/12/202423:16EDGAR2Form PRE 14A - Other preliminary proxy statements
18/12/202400:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202400:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202421:59EDGAR2Form 144 - Report of proposed sale of securities
16/12/202421:23EDGAR2Form 144 - Report of proposed sale of securities
16/12/202420:10EDGAR2Form 144 - Report of proposed sale of securities
25/11/202422:30EDGAR2Form 8-K - Current report
25/11/202412:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/11/202414:16GLOBEBioXcel Therapeutics Announces Pricing of $7.0 Million..
21/11/202422:47GLOBEBioXcel Therapeutics Announces Proposed Public Offering
21/11/202422:46EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21/11/202422:43EDGAR2Form 8-K - Current report
14/11/202415:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202413:00EDGAR2Form 8-K - Current report
14/11/202413:00GLOBEBioXcel Therapeutics Reports Third Quarter 2024 Financial..
12/11/202413:00GLOBEBioXcel Therapeutics Advances Pivotal Phase 3 Trials of..
08/11/202413:00GLOBEBioXcel Therapeutics to Report Third Quarter 2024 Financial..
29/10/202412:00GLOBEBioXcel Therapeutics to Present at ThinkEquity Conference
15/10/202413:00GLOBEBioXcel Therapeutics Announces U.S. Department of Defense..
09/10/202422:08EDGAR2Form 8-K - Current report
04/10/202403:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202403:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202403:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202422:40EDGAR2Form 144 - Report of proposed sale of securities
03/10/202422:33EDGAR2Form 144 - Report of proposed sale of securities
03/10/202422:17EDGAR2Form 144 - Report of proposed sale of securities
20/9/202422:05EDGAR2Form 8-K - Current report
19/9/202413:00EDGAR2Form 8-K - Current report
19/9/202413:00GLOBEBioXcel Therapeutics Announces Clinical Prioritization and..
18/9/202401:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202401:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202401:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202401:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202401:17EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
16/9/202423:42EDGAR2Form 144 - Report of proposed sale of securities
16/9/202423:26EDGAR2Form 144 - Report of proposed sale of securities
16/9/202423:16EDGAR2Form 144 - Report of proposed sale of securities
16/9/202419:23EDGAR2Form 144 - Report of proposed sale of securities
09/9/202422:15EDGAR2Form 8-K - Current report
05/9/202413:16EDGAR2Form 8-K - Current report
05/9/202413:00GLOBEBioXcel Therapeutics Announces Initiation of SERENITY..
07/8/202413:00GLOBEBioXcel Therapeutics to Participate in Canaccord Genuity..
06/8/202415:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202413:05EDGAR2Form 8-K - Current report
06/8/202413:00GLOBEBioXcel Therapeutics Reports Second Quarter 2024 Financial..
30/7/202413:00GLOBEBioXcel Therapeutics to Report Second Quarter 2024 Financial..
17/7/202422:41EDGAR2Form 8-K - Current report
16/7/202413:00EDGAR2Form 8-K - Current report
Apertura: 0,3698 Min: 0,3606 Max: 0,3999
Chiusura: 0,3669

La tua Cronologia

NASDAQ
BTAI
BioXcel Therapeutics
BFNX
APTUSD
Aptos
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network